Bristol-Myers Squibb
BMY
BMY
2,360 hedge funds and large institutions have $102B invested in Bristol-Myers Squibb in 2021 Q1 according to their latest regulatory filings, with 157 funds opening new positions, 993 increasing their positions, 936 reducing their positions, and 119 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,360
Holders Change
+8
Holders Change %
+0.34%
% of All Funds
41.56%
Holding in Top 10
70
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-10.26%
% of All Funds
1.23%
New
157
Increased
993
Reduced
936
Closed
119
Calls
$1.15B
Puts
$1.04B
Net Calls
+$112M
Net Calls Change
-$20M
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$327M |
| 2 |
Goldman Sachs
New York
|
+$258M |
| 3 |
BlackRock
New York
|
+$249M |
| 4 |
JPMorgan Chase & Co
New York
|
+$233M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$170M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$727M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$477M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$390M |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$283M |
| 5 |
Bank of New York Mellon
New York
|
-$263M |
